Dr. Jacquelyn Rose Dosal, MD

Dr. Dosal practices at The Dermatology House in Park City, Utah.

Dr. Dosal's NPI, 1114159837, was assigned on August 13, 2009. Dr. Dosal graduated from Ohio State College of Medicine in 2009. Dr. Dosal holds Florida license ME115424.

Dr. Dosal's primary practice is The Dermatology House, at 1526 Ute Blvd Suite 104 Suite 104, Park City, UT 84098-7575. The practice phone is (435) 602-1918.

Dr. Dosal's primary practice is The Dermatology House in Park City, Utah. The medical group on file is The Dermatology House.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dosal practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dosal's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dosal is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dosal's licenses on file in 3 states: Florida, Utah and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, minor head injury, minor injury on trunk and minor injury to a limb among the conditions Dr. Dosal treats.

CMS data shows 710 Medicare services from Dr. Dosal across 7 procedure codes in 2024, for 125 Medicare patients. Medicare paid $23,105 for them. Every service was in an office.

CMS counts 125 Medicare patients who saw Dr. Dosal in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dosal's median patient age at 57, with 61% women.

In 2024, Dr. Dosal wrote 154 Medicare Part D claims for 55 patients. 85% of them were for generic drugs. CMS names the drug for 71 of them, across 5 drugs with 11 or more claims each, at $46,764 in total drug cost. In 2023, CMS named 110 claims across 4 drugs.

Dr. Dosal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 162 procedures of removal of skin lesions by Dr. Dosal, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Dosal, published from 2011 to 2015. The most frequent topics are Rosacea and Acne Vulgaris. Dr. Dosal has published most often in J Invest Dermatol. Dr. Dosal's most frequent co-authors are Robert S. Kirsner, MD, Jonette Elizabeth Keri, MD, PhD and Carlos A. Ricotti, MD.

CMS Open Payments shows 331 general payments to Dr. Dosal from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $4,462.

Dr. Dosal graduated from Ohio State College of Medicine in 2009. Dr. Dosal is a member of AAD.

Dr. Dosal is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.